BMC Infectious Diseases

official impact factor 2.83
Search for
Advanced search
BMC Infectious Diseases
Tools
Share this article
Open Access Email this article to a friend

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

Carlo Torti*, Giuseppe Lapadula, Salvatore Casari, Massimo Puoti, Mark Nelson, Eugenia Quiros-Roldan, Daniele Bella, Giuseppe Pastore, Nicoletta Ladisa, Lorenzo Minoli, Giovanni Sotgiu, Francesco Mazzotta, Sergio Lo Caputo, Giovanni Di Perri, Gaetano Filice, Carmine Tinelli, Giampiero Carosi and the EPOKA-MASTER Study Group

BMC Infectious Diseases 2005, 5:58 doi:10.1186/1471-2334-5-58

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.